Hydroquinone is a skin-care active ingredient used to lighten areas of darkened skin. It is available as a 4 % concentration in a topical tube formulation and is regulated in Hong Kong as a prescription-only product for the treatment of hyperpigmentation disorders. While many brand-name products contain hydroquinone, this article focuses on the active ingredient itself.
Hydroquinone belongs to the class of depigmenting agents. It inhibits the enzyme tyrosinase, which is essential for the production of melanin-the pigment that gives skin its color. By reducing melanin synthesis, hydroquinone gradually lightens hyperpigmented patches. The effect is usually visible after several weeks of consistent use. Because the product is applied topically, systemic absorption is minimal, and the action is confined to the treated skin surface.
Hydroquinone is approved by the Hong Kong Department of Health for the treatment of benign hyperpigmentation conditions, including:
The medication is intended for adult patients with stable skin conditions. It is not indicated for fungal infections, bacterial skin diseases, or malignant lesions.
If you fall into any of the above categories, consult a dermatologist before starting treatment.
These effects are usually transient and can be mitigated by using a gentle moisturizer.
Hydroquinone has limited systemic absorption, so pharmacokinetic drug interactions are rare. However, combining hydroquinone with other potent topical agents (e.g., tretinoin, corticosteroids, or other depigmenting creams) may increase irritation risk. Always inform your dermatologist of any concurrent topical treatments.
Missed dose: Apply the missed dose as soon as remembered, unless it is near the time of the next scheduled application-then skip the missed dose. Do not double the amount.
Overdose: Excessive topical application can cause severe irritation or systemic absorption. If large amounts are inadvertently applied, rinse the area with water and seek medical advice.
Discontinuation: Gradual tapering is not required, but a short break after the treatment course reduces the chance of rebound hyperpigmentation.
This article provides educational information about hydroquinone and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Hydroquinone is intended for localized treatment of specific hyperpigmented patches. Applying it to large surface areas increases the risk of irritation and ochronosis, so use should be limited to the areas prescribed by a dermatologist.
Visible lightening typically begins after 2-4 weeks of consistent daily application, with full results often requiring 8-12 weeks of intermittent treatment.
Concurrent use may enhance skin irritation. If a dermatologist recommends both, they will usually advise alternating application days or using a lower concentration of hydroquinone.
Stop the product immediately, rinse the area with cool water, and contact a healthcare professional for evaluation and possible alternative therapy.
Yes, some individuals develop contact dermatitis, characterized by redness, itching, or swelling. Patch testing can help determine if you are hypersensitive.
Hydroquinone can lighten solar lentigines (age spots) when used as directed, but results vary depending on depth of pigmentation and skin type.
Absolutely. Hydroquinone increases photosensitivity, and sun exposure can reverse its lightening effects and exacerbate hyperpigmentation.
Avoid applying hydroquinone to areas with active eczema or compromised skin barrier, as it may worsen irritation.
Systemic absorption is minimal, so systemic side effects are rare. However, over-application or use on broken skin can increase absorption and lead to unexpected reactions.
Many over-the-counter products contain lower concentrations of hydroquinone (≤2 %) or alternative agents. Prescription-strength 4 % hydroquinone provides a stronger melanogenesis inhibition, but it also requires closer medical supervision.
